Salt & Pepper Labs
Research products

Research catalog
built for traceability.

These pages organize research-product identity, stated strength, batch documentation, analytical-testing context, and source records. They intentionally do not provide human-use protocols, dosing, injection instructions, or medical claims.

Semaglutide 10 mg RESEARCH USE ONLY

Semaglutide

10 mg

Reference entry for identity, batch documentation, analytical records, and sourcing context.

Documentation framework →
Tirzepatide 10 mg / 20 mg RESEARCH USE ONLY

Tirzepatide

10 mg / 20 mg

Reference entry for identity, batch documentation, analytical records, and sourcing context.

Documentation framework →
Retatrutide 10 mg RESEARCH USE ONLY

Retatrutide

10 mg

Reference entry for identity, batch documentation, analytical records, and sourcing context.

Documentation framework →
NAD+ 500 mg RESEARCH USE ONLY

NAD+

500 mg

Reference entry for identity, batch documentation, analytical records, and sourcing context.

Documentation framework →
KLOW80 80 mg blend RESEARCH USE ONLY

KLOW80

80 mg blend

Reference entry for identity, batch documentation, analytical records, and sourcing context.

Documentation framework →
Semax 10 mg RESEARCH USE ONLY

Semax

10 mg

Reference entry for identity, batch documentation, analytical records, and sourcing context.

Documentation framework →
Tesamorelin 10 mg RESEARCH USE ONLY

Tesamorelin

10 mg

Reference entry for identity, batch documentation, analytical records, and sourcing context.

Documentation framework →
Glutathione 1500 mg RESEARCH USE ONLY

Glutathione

1500 mg

Reference entry for identity, batch documentation, analytical records, and sourcing context.

Documentation framework →
MOTS-c 10 mg RESEARCH USE ONLY

MOTS-c

10 mg

Reference entry for identity, batch documentation, analytical records, and sourcing context.

Documentation framework →
Research-use statement: Product names and strengths shown here are catalog/reference information only. Availability, exact batch documentation, and final commercial terms should be confirmed before publication or ordering.